Diagnosis and treatment of nonalcoholic fatty liver disease in patients with metabolic syndrome: potential of cardiac and antidiabetic medications

Diagnosis and treatment of nonalcoholic fatty liver disease in patients with metabolic syndrome: potential of cardiac and antidiabetic medications

According to recent guidelines of AASLD, AGA and ACG, NAFLD is a liver disease accompanied by the accumulation of fatty acid content greater than 5% of hepatocytes weight, absence of substantial alcohol consumption (20 g per day for men, 10 g per day for women), absence of hepatitis viruses and othe...

Full description

Bibliographic Details
Main Authors: S. V. Nedogoda, T. N. Sanina, T. A. Chalyabi, I. N. Barykina, V. V. Tsoma, E. V. Chumachek, A. S. Salasyuk, V. Y. Khripaeva, V. O. Smirnova
Format: Article
Language:Russian
Published: Remedium Group LLC 2014-12-01
Series:Медицинский совет
Subjects:
нажбп
метаболический синдром
ожирение
орлистат
аторвастатин
липтонорм
nafld
metabolic syndrome
obesity
orlistat
atorvastatin
liptonorm
Online Access:https://www.med-sovet.pro/jour/article/view/672

Internet

https://www.med-sovet.pro/jour/article/view/672

Similar Items